Envestnet Portfolio Solutions Inc. Sells 359 Shares of Humana Inc. (NYSE:HUM)

Envestnet Portfolio Solutions Inc. reduced its position in Humana Inc. (NYSE:HUM) by 6.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,283 shares of the insurance provider’s stock after selling 359 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in Humana were worth $1,340,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. FPC Investment Advisory Inc. acquired a new stake in shares of Humana during the 4th quarter valued at about $27,000. Centricity Wealth Management LLC acquired a new stake in Humana during the fourth quarter valued at approximately $30,000. LFA Lugano Financial Advisors SA boosted its holdings in Humana by 56.3% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider’s stock valued at $32,000 after purchasing an additional 45 shares in the last quarter. OFI Invest Asset Management bought a new stake in shares of Humana in the 4th quarter valued at approximately $33,000. Finally, Atwood & Palmer Inc. raised its holdings in shares of Humana by 64.5% in the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock worth $39,000 after buying an additional 60 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on HUM shares. Piper Sandler upped their price target on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a research report on Wednesday, January 15th. StockNews.com lowered shares of Humana from a “buy” rating to a “hold” rating in a report on Tuesday. Barclays lifted their price target on shares of Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a report on Thursday, February 13th. Morgan Stanley decreased their price objective on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a research note on Wednesday, February 12th. Finally, Cantor Fitzgerald reiterated a “neutral” rating and issued a $290.00 target price on shares of Humana in a research note on Wednesday, February 12th. Nineteen investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $285.68.

Insider Transactions at Humana

In related news, insider Timothy S. Huval sold 3,703 shares of the business’s stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares in the company, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.37% of the company’s stock.

Humana Stock Down 0.2 %

Shares of NYSE:HUM opened at $266.33 on Friday. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The stock has a market cap of $32.14 billion, a price-to-earnings ratio of 26.77, a P/E/G ratio of 2.05 and a beta of 0.57. The company has a 50 day moving average of $271.33 and a 200-day moving average of $277.52. Humana Inc. has a one year low of $213.31 and a one year high of $406.46.

Humana (NYSE:HUM) last issued its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, sell-side analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.33%. The ex-dividend date of this dividend is Friday, March 28th. Humana’s dividend payout ratio (DPR) is currently 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.